title: Decreased levels of uric acid after oral glucose challenge is associated with triacylglycerol levels and degree of insulin resistance.
abstract: Hyperuricaemia is one of the components of metabolic syndrome. Both oxidative stress and hyperinsulinism are important variables in the genesis of this syndrome and have a close association with uric acid (UA). We evaluated the effect of an oral glucose challenge on UA concentrations. The study included 656 persons aged 18 to 65 years. Glycaemia, insulin, UA and plasma proteins were measured at baseline and 120 min after an oral glucose tolerance test (OGTT). The baseline sample also included measurements of total cholesterol, triacylglycerol (TAG) and HDL-cholesterol. Insulin resistance was calculated with the homeostasis model assessment. UA levels were significantly lower after the OGTT (281.93 (sd 92.19) v. 267.48 (sd 90.40) micromol/l; P < 0.0001). Subjects with a drop in UA concentrations >40.86 micromol/l (>75th percentile) had higher plasma TAG levels (P = 0.0001), baseline insulin (P = 0.02) and greater insulin resistance (P = 0.034). Women with a difference in plasma concentrations of UA above the 75th percentile had higher baseline insulin levels (P = 0.019), concentration of plasma TAG (P = 0.0001) and a greater insulin resistance index (P = 0.029), whereas the only significant difference in men was the level of TAG. Multiple regression analysis showed that the basal TAG levels, insulin at 120 min, glycaemia at 120 min and waist:hip ratio significantly predicted the variance in the UA difference (r2 0.077). Levels of UA were significantly lower after the OGTT and the individuals with the greatest decrease in UA levels are those who have greater insulin resistance and higher TAG levels.
authors.affiliation: Servicio de Endocrinología y Nutrición, Hospital Clínico Universitario Virgen de la Victoria, Málaga and CIBER Fisiopatología de la obesidad y nutrición CB06/03 Instituto de Salud Carlos III, Málaga, Spain. fjtinahones@terra.es
authors.forename: F J
authors.initials: FJ
authors.lastname: Tinahones
authors.forename: F
authors.initials: F
authors.lastname: Cardona
authors.forename: G
authors.initials: G
authors.lastname: Rojo-Martínez
authors.forename: M C
authors.initials: MC
authors.lastname: Almaraz
authors.forename: I
authors.initials: I
authors.lastname: Cardona
authors.forename: J
authors.initials: J
authors.lastname: Vázquez-Mellado
authors.forename: L
authors.initials: L
authors.lastname: Garrido-Sánchez
authors.forename: E
authors.initials: E
authors.lastname: Collantes
authors.forename: F
authors.initials: F
authors.lastname: Soriguer
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000032:analysis; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D005260:Female; D005951:Glucose Tolerance Test; D006706:Homeostasis / Q000187:drug effects; D006801:Humans; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance; D008297:Male; D008875:Middle Aged; D018384:Oxidative Stress / Q000502:physiology*; D012044:Regression Analysis; D014280:Triglycerides / Q000097:blood*; D014527:Uric Acid / Q000097:blood*
chemical_list: D001786:Blood Glucose; D008076:Cholesterol, HDL; D007328:Insulin; D014280:Triglycerides; D014527:Uric Acid; D002784:Cholesterol